MYRICX PHARMA LIMITED
Company number 12082645 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£8,684,860
Balance sheet as at 2023-07-31
What it does
research and development in biotechnology, specifically cancer treatment in humans.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-07-03
- Employees
- 8 (2023 accounts · was 6 in 2022)
- Registered office
- 2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London, United Kingdom, W12 7FQ
- Postcode
- W12 7FQ
- Capital
- 964 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2025-07-31
- Next due by
- 2027-04-30
- Financial year end
- 31 July
Confirmation statement
- Last statement dated
- 2026-07-02
- Next due by
- 2027-07-16
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 0 current · 19 resigned
Group structure
Controlled by Novartis Ag (CHE-103.867.266) — since 2026-08-28
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB886837 (Tier 1), registered since 2025.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- myricxpharma.com
Previous registered addresses 1
| Address | Changed on |
|---|---|
| C/O PENNINGTONS MANCHES COOPER LLP APEX PLAZA, FORBURY ROAD, READING, RG1 1AX, UNITED KINGDOM | 2019-12-20 |
At this address
Among the biggest employers
of 83 similar companies in W, with 8 staff.
Competitors London
This company ranks 140 among research and experimental development on biotechnology in London.
The class of 2019
39%
of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.
A fact about the year, not a forecast for this company.